Policy | March 06, 2024
Dr. Mandaviya inaugurates Sadhana Nitro Chem’s Para Amino Phenol bulk drug plant
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
These re-agent and diagnostic test kits come with 99.7% accuracy
The company recently received CEP certificate approval for Losartan Potassium by EDQM
Revenue from Operations stood at Rs. 2,607 crore, 25% YoY growth. Domestic revenue at Rs. 2,400 crore, 20% YoY growth and export revenue at Rs. 207 crore, 118% YoY growth
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
The company has secured two orders for male condoms from CMSS worth Rs. 9.65 crores and Rs. 6.58 crores respectively
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
